Proqr Therapeutics N V stock is traded at $1.26, with a volume of 353,866. It is down -3.82% in the last 24 hours and down -22.22% over the past month. ProQR Therapeutics NV is a biopharmaceutical company. It discovers and develops RNA therapeutics for patients with severe genetic rare diseases such as cystic fibrosis, Leber congenital amaurosis type 10, and dystrophic epidermolysis bullosa. The only reportable segment of the company is the discovery and development of different, RNA-based therapeutics. Geographically, the company operates in United States.
Previous Close:
$1.31
Open:
$1.32
24h Volume:
353,866
Relative Volume:
0.56
Market Cap:
$177.81M
Revenue:
$15.53M
Net Income/Loss:
-$52.71M
P/E Ratio:
-
EPS:
-$0.5025
Net Cash Flow:
-$59.00M
1W Performance:
-5.26%
1M Performance:
-22.22%
6M Performance:
-21.25%
1Y Performance:
-41.67%
1-Day Range:
$1.25$1.35
1-Week Range:
$1.25$1.41
52-Week Range:
$1.20$2.49
Proqr Therapeutics N V Stock (PRQR) Company Profile
Market Cap
Revenue
Net Income
Cash Flow
EPS